(Q44401515)

2 December 2017

title

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma (English)

1 reference

Adaptive radiation therapy

2 December 2017

main subject

0 references

author name string

T. Cheng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

23 December 2023

P. Forsyth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

23 December 2023

A. Chaudhry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

23 December 2023

D. Morris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

23 December 2023

S. Glück

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

23 December 2023

J. A. Russell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

23 December 2023

D. A. Stewart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

23 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

2 December 2017

https://www.nature.com/articles/1703917.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692608

https://www.nature.com/articles/1703917

23 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703917

https://www.nature.com/articles/1703917.pdf

23 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703917

Bone Marrow Transplantation

23 December 2023

published in

1 reference

2 December 2017

volume

31

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

679-685

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703917

2 December 2017

exact match

0 references

cites work

Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Primary lymphoma of brain: results of management of a modern cohort with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Combined modality therapy for primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Treatment for primary CNS lymphoma: the next step

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Pharmacology of agents used in bone marrow transplant conditioning regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Primary central nervous system lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

7 January 2021

Long-term survival in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

7 January 2021

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

7 January 2021

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

7 January 2021

Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

7 January 2021

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

7 January 2021

Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703917

7 January 2021

26

10

15

R Marks

1999

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703917

23 December 2023

Identifiers

1 reference

2 December 2017

1 reference